Impaired degradation of WNK1 and WNK4 kinases causes PHAII in mutant KLHL3 knock-in mice
Open Access
- 12 May 2014
- journal article
- research article
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 23 (19) , 5052-5060
Abstract
Pseudohypoaldosteronism type II (PHAII) is a hereditary disease characterized by salt-sensitive hypertension, hyperkalemia and metabolic acidosis, and genes encoding with-no-lysine kinase 1 (WNK1) and WNK4 kinases are known to be responsible. Recently, Kelch-like 3 (KLHL3) and Cullin3, components of KLHL3-Cullin3 E3 ligase, were newly identified as responsible for PHAII. We have reported that WNK4 is the substrate of KLHL3-Cullin3 E3 ligase-mediated ubiquitination. However, WNK1 and Na–Cl cotransporter (NCC) were also reported to be a substrate of KLHL3-Cullin3 E3 ligase by other groups. Therefore, it remains unclear which molecule is the target(s) of KLHL3. To investigate the pathogenesis of PHAII caused by KLHL3 mutation, we generated and analyzed KLHL3R528H/+ knock-in mice. KLHL3R528H/+ knock-in mice exhibited salt-sensitive hypertension, hyperkalemia and metabolic acidosis. Moreover, the phosphorylation of NCC was increased in the KLHL3R528H/+ mouse kidney, indicating that the KLHL3R528H/+ knock-in mouse is an ideal mouse model of PHAII. Interestingly, the protein expression of both WNK1 and WNK4 was significantly increased in the KLHL3R528H/+ mouse kidney, confirming that increases in these WNK kinases activated the WNK-OSR1/SPAK-NCC phosphorylation cascade in KLHL3R528H/+ knock-in mice. To examine whether mutant KLHL3 R528H can interact with WNK kinases, we measured the binding of TAMRA-labeled WNK1 and WNK4 peptides to full-length KLHL3 using fluorescence correlation spectroscopy, and found that neither WNK1 nor WNK4 bound to mutant KLHL3 R528H. Thus, we found that increased protein expression levels of WNK1 and WNK4 kinases cause PHAII by KLHL3 R528H mutation due to impaired KLHL3-Cullin3-mediated ubiquitination.Keywords
This publication has 45 references indexed in Scilit:
- Decrease of WNK4 ubiquitination by disease-causing mutations of KLHL3 through different molecular mechanismsBiochemical and Biophysical Research Communications, 2013
- The CUL3–KLHL3 E3 ligase complex mutated in Gordon's hypertension syndrome interacts with and ubiquitylates WNK isoforms: disease-causing mutations in KLHL3 and WNK4 disrupt interactionBiochemical Journal, 2013
- Impaired KLHL3-Mediated Ubiquitination of WNK4 Causes Human HypertensionCell Reports, 2013
- Activation of the renal Na + :Cl − cotransporter by angiotensin II is a WNK4-dependent processProceedings of the National Academy of Sciences, 2012
- Mutations in kelch-like 3 and cullin 3 cause hypertension and electrolyte abnormalitiesNature, 2012
- Impaired phosphorylation of Na + -K + -2Cl − cotransporter by oxidative stress-responsive kinase-1 deficiency manifests hypotension and Bartter-like syndromeProceedings of the National Academy of Sciences, 2011
- The Cullin 3 substrate adaptor KLHL20 mediates DAPK ubiquitination to control interferon responsesThe EMBO Journal, 2010
- Role of the WNK‐activated SPAK kinase in regulating blood pressureEMBO Molecular Medicine, 2010
- Angiotensin II signaling increases activity of the renal Na-Cl cotransporter through a WNK4-SPAK-dependent pathwayProceedings of the National Academy of Sciences, 2009
- Pathogenesis and treatment of autosomal-dominant nephrogenic diabetes insipidus caused by an aquaporin 2 mutationProceedings of the National Academy of Sciences, 2006